Taxane anticancer agents

Details for Australian Patent Application No. 2001245582 (hide)

Owner Bristol-Myers Squibb Company

Inventors Wittman, Mark D.; Xue, Qiufen May; Scola, Paul M.; Schwartz, Wendy S.; Kadow, John F.; Wu, Mu-jen

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001245582

PCT Pub. Number WO01/70718

Priority 60190174 17.03.00 US

Filing date 9 March 2001

Wipo publication date 3 October 2001

Acceptance publication date 28 July 2005

International Classifications

C07D 305/14 Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms

A61K 031/337 - having four-membered rings, e.g. taxol

Event Publications

28 July 2005 Application Accepted

  Published as AU-B-2001245582

24 November 2005 Standard Patent Sealed

2 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001245583

2001245581